Jinan Jintai Pharmaceutical Technology Development Co., Ltd. announced that it will receive $12 million in an equity round of funding on November 8, 2019. The transaction will include participation from returning investor Shandong Jintai Group Co., Ltd. (SHSE:600385). Pursuant to the transaction, the registered capital of the company will increase to $12 million.